Evidence map›Paper›PMID 26793265›Full record

ReviewAIDS research and therapy2016

Sexually transmitted infections and pre-exposure prophylaxis: challenges and opportunities among men who have sex with men in the US.

Hyman M Scott, Jeffrey D Klausner

Abstract readReview
In one paragraph

Review in AIDS research and therapy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Analysis of High-Risk Sexual Behavior among Polish University Students.International journal of environmental research and public health · 2021
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. PrEP 1.0 and Beyond: Optimizing a Biobehavioral Intervention.Journal of acquired immune deficiency syndromes (1999) · 2019
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Hyman M ScottBridge HIV, San Francisco Department of Public Health, San Francisco, CA USA.
Jeffrey D KlausnerDivision of Infectious Diseases: Global Health, Department of Medicine, University of California, Los Angeles, Los Angeles, CA USA.

Funding

TRAINEESHIPS IN AIDS PREVENTION STUDIEST32MH019105 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Carol Suzanne Camlin, Glenn-Milo Santos · 1989 to 2026
$15.3M
PHASTT: A mobile Personalized HIV and STI Testing Tool for young Black menK23MH104116 · NIMH · PUBLIC HEALTH FOUNDATION ENTERPRISES · PI SCOTT, HYMAN · 2015 to 2018
$762k
NIMH NIH HHS K23 MH104116NIMH NIH HHS T32 MH019105
6 · The paper itself

Abstract

Pre-Exposure Prophylaxis (PrEP) has shown high efficacy in preventing human immunodeficiency virus (HIV) infection among men who have sex with men (MSM) in several large clinical trials, and more recently in "real world" reports of clinical implementation and a PrEP demonstration project. Those studies also demonstrated high bacterial sexually transmitted infection (STI) incidence and raised the discussion of how PrEP may impact STI control efforts, especially in the setting of increasing Neisseria gonorrhoeae antimicrobial resistance and the increase in syphilis cases among MSM. Here, we discuss STIs as a driver of HIV transmission risk among MSM, and the potential opportunities and challenges for STI control afforded by expanded PrEP implementation among high-risk MSM.

Indexed as

Homosexuality, MalePre-Exposure ProphylaxisDrug Resistance, BacterialGonorrheaHIV InfectionsHumansIncidenceMaleMass ScreeningRisk FactorsSexually Transmitted Diseases, BacterialSyphilisUnited StatesHIVMSMPrEPSTIs

Identifiers

PMID26793265
PMCPMC4719214

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.